The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: Characterization of domains necessary for subcellular localization and sumolation

Experimental Cell Research

Volumn 290, Issue 1, 2003, Pages 13-27

  Weger, Stefan ^a   Hammer, Eva ^a   Engstler, Markus ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Nuclear domains 10; P53; PML; RING finger; SUMO; SUMO 1 E3 ligase; Topoisomerase I; Topors; UBC9

Indexed keywords

BINDING PROTEIN; DNA TOPOISOMERASE; ENZYME; LYSINE; MUTANT PROTEIN; PROTEIN P53; PROTEIN UBC9; SUMO 1 PROTEIN; TOPORS; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TWO HYBRID SYSTEM; YEAST;

EID: 0141569249     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00292-1     Document Type: Article

References (46)

1. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67:1998;425-479.
2. Melchior F. SUMO - nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16:2000;591-626.
3. Jentsch S., Pyrowolakis G. Ubiquitin and its kin how close are the family ties? Trends Cell Biol. 10:2000;335-342.
4. Hochstrasser M. There's the rub a novel ubiquitin-like modification linked to cell cycle regulation . Genes Dev. 12:1998;901-907.
5. Johnson E.S., Schwienhorst I., Dohmen R.J., Blobel G. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16:1997;5509-5519.
6. Johnson E.S., Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272:1997;26799-26802.
7. Hay R.T. Protein modification by SUMO. Trends Biochem. Sci. 26:2001;332-333.
8. Saitoh H., Sparrow D.B., Shiomi T., Pu R.T., Nishimoto T., Mohun T.J., Dasso M. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8:1998;121-124.
9. Azuma Y., Tan S.H., Cavenagh M.M., Ainsztein A.M., Saitoh H., Dasso M. Expression and regulation of the mammalian SUMO-1 E1 enzyme. FASEB J. 15:2001;1825-1827.
10. Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 108:2002;109-120.
11. Johnson E.S., Gupta A.A. An E3 like factor that promotes SUMO conjugation to the yeast septins. Cell. 106:2002;735-744.
12. Kahyo T., Nishida T., Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell. 8:2001;713-718.
13. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:2001;3088-3103.
14. Schmidt D., Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA. 99:2002;2872-2877.
15. Kamitani T., Nguyen H.P., Yeh E.T. Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272:1997; 14001-14004.
16. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 88:1997;97-107.
17. Kamitani T., Nguyen H.P., Kito K., Fukuda-Kamitani T., Yeh E.T. Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J. Biol. Chem. 273:1998;3117-3120.
18. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:1998;61-70.
19. Sternsdorf T., Jensen K., Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139:1997;1621-1634.
20. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell. 2:1998;233-239.
21. Kim Y.H., Choi C.Y., Kim Y. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl. Acad. Sci. USA. 96:1999;12350-12355.
22. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S.E., Scheffner M., Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBo J. 18:1999;6462-6471.
23. Rodriguez M.S., Desterro J.M., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461.
24. Buschmann T., Fuchs S.Y., Lee C.G., Pan Z.Q., Ronai Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell. 101:2000;753-762.
25. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275:2000;13321-13329.
26. Rangasamy D., Woytek K., Khan S.A., Wilson V.G. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J. Biol. Chem. 275:2000;37999-38004.
27. Chakrabarti S.R., Sood R., Nandi S., Nucifora G. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. USA. 97:2000;13281-13285.
28. Hatta, M., Fukamizu, A. PODs in the nuclear spot: enigmas in the magician's pot, Sci. STKE (2001) PE1.
29. Maul G.G., Negorev D., Bell P., Ishov A.M. Review properties and assembly mechanisms of ND10, PML bodies, or PODs . J. Struct. Biol. 129:2000;278-287.
30. Maul G.G. Nuclear domain 10 the site of DNA virus transcription and replication. Bioessays. 20:1998;660-667.
31. Seeler J.S., Dejean A. The PML nuclear bodies actors or extras? Curr. Opin. Genet. Dev. 9:1999;362-367.
32. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K., Pandolfi P.P., Will H., Schneider C., Del Sal G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19:2000;6185-6195.
33. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Paolo Pandolfi P. The function of PML in p53 dependent apoptosis. Nat. Cell Biol. 2:2000;730-736.
34. Torii S., Egan D.A., Evans R.A., Reed J.C. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18:1999;6037-6049.
35. Haluska P. Jr., Saleem A., Rasheed Z., Ahmed F., Su E.W., Liu L.F., Rubin E.H. Interaction between human topoisomerase 1 and a novel RING finger/arginine-serine protein. Nucleic Acids Res. 27:1999;2538-2544.
36. Zhou R., Wen H., Ao S.Z. Identification of a novel gene encoding a p53-associated protein. Gene. 235:1999;93-101.
37. Weger S., Hammer E., Heilbronn R. Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep 78/68 proteins and enhances AAV-2 gene expression. J. Gen. Virol. 83:2002;511-516.
38. Georgiev O., Bourquin J.P., Gstaiger M., Knoepfel L., Schaffner W., Hovens C. Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins. Gene. 168:1996;165-167.
39. Minty A., Dumont X., Kaghad M., Caput D. Covalent Modification of p73alpha by SUMO-1 Two-hybrid screening with p73 identifies novel SUMO-1 Interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275:2000;36316-36323.
40. Tanaka K., Nishide J., Okazaki K., Kato H., Niwa O., Nakagawa T., Matsuda H., Kawamukai M., Murakami Y. Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol. Cell Biol. 19:1999;8660-8672.
41. Doucas V., Ishov A.M., Romo A., Juguilon H., Weitzman M.D., Evans R.M., Maul G.G. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:1996;196-207.
42. Duprez E., Saurin A.J., Desterro J.M., Lallemand-Breitenbach V., Howe K., Boddy M.N., Solomon E., de The H., Hay R.T., Freemont P.S. SUMO-1 modification of the acute promyelocytic leukaemia protein PML implications for nuclear localisation . J. Cell Sci. 112:1999;381-393.
43. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:1996;267-271.
44. Yasugi T., Howley P.M. Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9. Nucleic Acids Res. 24:1996;2005-2010.
45. Rasheed Z.A., Saleem A., Ravee Y., Pandolfi P.P., Rubin E.H. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp. Cell Res. 277:2002;152-160.
46. Sternsdorf T., Jensen K., Reich B., Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274:1999;12555-12566.